These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 25151383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Participation of galactosylceramide and sulfatide in glycosynapses between oligodendrocyte or myelin membranes.
    Boggs JM, Gao W, Zhao J, Park HJ, Liu Y, Basu A.
    FEBS Lett; 2010 May 03; 584(9):1771-8. PubMed ID: 19941861
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Myelin glycosphingolipids, galactosylceramide and sulfatide, participate in carbohydrate-carbohydrate interactions between apposed membranes and may form glycosynapses between oligodendrocyte and/or myelin membranes.
    Boggs JM, Gao W, Hirahara Y.
    Biochim Biophys Acta; 2008 Mar 03; 1780(3):445-55. PubMed ID: 18035062
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of liposomes containing cerebroside and cerebroside sulfate on cytoskeleton of cultured oligodendrocytes.
    Boggs JM, Wang H.
    J Neurosci Res; 2001 Oct 15; 66(2):242-53. PubMed ID: 11592120
    [Abstract] [Full Text] [Related]

  • 8. Trans interactions between galactosylceramide and cerebroside sulfate across apposed bilayers.
    Boggs JM, Menikh A, Rangaraj G.
    Biophys J; 2000 Feb 15; 78(2):874-85. PubMed ID: 10653800
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice.
    Hirahara Y, Bansal R, Honke K, Ikenaka K, Wada Y.
    Glia; 2004 Feb 15; 45(3):269-77. PubMed ID: 14730700
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I, Büssow H, Gieselmann V, Eckhardt M.
    Glia; 2005 Nov 15; 52(3):190-8. PubMed ID: 15968630
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.
    Dyer CA.
    Mol Neurobiol; 1993 Nov 15; 7(1):1-22. PubMed ID: 8391270
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carbohydrate-coated fluorescent silica nanoparticles as probes for the galactose/3-sulfogalactose carbohydrate-carbohydrate interaction using model systems and cellular binding studies.
    Zhao J, Liu Y, Park HJ, Boggs JM, Basu A.
    Bioconjug Chem; 2012 Jun 20; 23(6):1166-73. PubMed ID: 22551003
    [Abstract] [Full Text] [Related]

  • 19. Galactolipids in the formation and function of the myelin sheath.
    Dupree JL, Suzuki K, Popko B.
    Microsc Res Tech; 1998 Jun 01; 41(5):431-40. PubMed ID: 9672425
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.